117 related articles for article (PubMed ID: 11216953)
21. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Vizir VA; Berezin AE
Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
[TBL] [Abstract][Full Text] [Related]
22. Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications.
Guazzi M
Clin Sci (Lond); 2000 Jun; 98(6):633-41. PubMed ID: 10814599
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
24. Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Guo X; Wang J; Elimban V; Dhalla NS
Can J Physiol Pharmacol; 2008 Apr; 86(4):139-47. PubMed ID: 18418421
[TBL] [Abstract][Full Text] [Related]
25. Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production.
Guazzi M; Arena R; Vicenzi M; Guazzi MD
Acta Physiol (Oxf); 2009 Jun; 196(2):267-77. PubMed ID: 19032601
[TBL] [Abstract][Full Text] [Related]
26. Insulin improves alveolar-capillary membrane gas conductance in type 2 diabetes.
Guazzi M; Oreglia I; Guazzi MD
Diabetes Care; 2002 Oct; 25(10):1802-6. PubMed ID: 12351481
[TBL] [Abstract][Full Text] [Related]
27. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
[TBL] [Abstract][Full Text] [Related]
28. Decrease by ACE-inhibition of the excessive alveolar-capillary membrane resistance to gas transfer in chronic heart failure.
Guazzi M; Agostoni P
Cardiologia; 1998 Jun; 43(6):625-30. PubMed ID: 9675962
[TBL] [Abstract][Full Text] [Related]
29. Effects of body position and age on membrane diffusing capacity and pulmonary capillary blood volume.
Chang SC; Chang HI; Liu SY; Shiao GM; Perng RP
Chest; 1992 Jul; 102(1):139-42. PubMed ID: 1623741
[TBL] [Abstract][Full Text] [Related]
30. Alveolar-capillary membrane diffusion measurement by nitric oxide inhalation in heart failure.
Magini A; Apostolo A; Salvioni E; Italiano G; Veglia F; Agostoni P
Eur J Prev Cardiol; 2015 Feb; 22(2):206-12. PubMed ID: 24165475
[TBL] [Abstract][Full Text] [Related]
31. [Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
Vizir VA; Berezin AE
Klin Med (Mosk); 2000; 78(7):36-9. PubMed ID: 10979640
[TBL] [Abstract][Full Text] [Related]
32. Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism.
Magri P; Rao MA; Cangianiello S; Bellizzi V; Russo R; Mele AF; Andreucci M; Memoli B; De Nicola L; Volpe M
Circulation; 1998 Dec 22-29; 98(25):2849-54. PubMed ID: 9860786
[TBL] [Abstract][Full Text] [Related]
33. Pentoxifylline improves pulmonary gas exchange.
Haas F; Bevelaqua F; Levin N; Salazar-Schicchi J; Reggiani JL; Axen K; Pineda H
Chest; 1990 Mar; 97(3):621-7. PubMed ID: 2306966
[TBL] [Abstract][Full Text] [Related]
34. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
35. Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Davie AP; Dargie HJ; McMurray JJ
Circulation; 1999 Jul; 100(3):268-73. PubMed ID: 10411851
[TBL] [Abstract][Full Text] [Related]
36. Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.
Olson LJ; Snyder EM; Beck KC; Johnson BD
J Card Fail; 2006 May; 12(4):299-306. PubMed ID: 16679264
[TBL] [Abstract][Full Text] [Related]
37. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
38. Evolving changes in lung interstitial fluid content after acute myocardial infarction: mechanisms and pathophysiological correlates.
Guazzi M; Arena R; Guazzi MD
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1357-64. PubMed ID: 18192218
[TBL] [Abstract][Full Text] [Related]
39. Diffusing capacity of the lung for carbon monoxide.
MacIntyre NR
Respir Care Clin N Am; 1997 Jun; 3(2):221-33. PubMed ID: 9390909
[TBL] [Abstract][Full Text] [Related]
40. Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure.
Guazzi M; Reina G; Tumminello G; Guazzi MD
J Appl Physiol (1985); 2004 Nov; 97(5):1866-73. PubMed ID: 15220300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
